Ohnishi N, Yonekawa Y, Nakasako S, Nagasawa K, Yokoyama T, Yoshioka M, Kuroda K
Department of Hospital Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Japan.
Biol Pharm Bull. 1999 May;22(5):527-31. doi: 10.1248/bpb.22.527.
The effects of oral co- and pre-administration of Sho-seiryu-to extract powder (TJ-19, 1 g/kg), a widely used Kampo (traditional Chinese herbal) medicine, on the pharmacokinetics of an anti-epileptic drug, carbamazepine (CBZ), and its active metabolite (carbamazepine-10,11-epoxide, CBZ-E) after oral administration of CBZ (50 mg/kg) were examined in male rats. The simultaneous administration of TJ-19 significantly lengthened the time to reach the peak plasma concentration (Tmax), but did not influence the peak plasma concentration, area under the plasma concentration-time curve or terminal elimination half-life (t1/2). Each parameter for CBZ or CBZ-E with a single pretreatment with TJ-19 was not significantly different from that with the vehicle. Tmax and the elimination rate constant for CBZ were significantly increased by 1-week repeated pretreatment with TJ-19, by 83% (p<0.01) and 88% (p<0.001), respectively. t1/2 and the mean residence time from zero to infinity (MRT0-infinity) in the TJ-19 pretreatment group were significantly shortened, by 52 and 34% (p<0.005), respectively. No significant difference in the bound fraction of each drug at two concentrations (1 and 10 microg/ml) was observed between the control and TJ-19 pretreatment groups. These results indicate that simultaneous oral administration of TJ-19 delays the oral absorption of CBZ, while 1-week repeated pretreatment with TJ-19 accelerates the metabolism of CBZ in rats, without affecting the protein binding of CBZ.
探讨了广泛应用的汉方(传统中药)方剂柴胡龙骨牡蛎汤提取物粉末(TJ-19,1 g/kg)口服联合及预给药对雄性大鼠口服抗癫痫药物卡马西平(CBZ,50 mg/kg)后其药代动力学及活性代谢产物(卡马西平-10,11-环氧化物,CBZ-E)的影响。同时给予TJ-19显著延长了达血浆峰浓度时间(Tmax),但不影响血浆峰浓度、血浆浓度-时间曲线下面积或末端消除半衰期(t1/2)。TJ-19单次预处理后CBZ或CBZ-E的各参数与溶媒组相比无显著差异。TJ-19连续1周重复预处理使CBZ的Tmax和消除速率常数分别显著增加83%(p<0.01)和88%(p<0.001)。TJ-19预处理组的t1/2和从零到无穷大的平均驻留时间(MRT0-∞)分别显著缩短52%和34%(p<0.005)。在对照和TJ-19预处理组之间,未观察到两种浓度(1和10μg/ml)下各药物结合分数的显著差异。这些结果表明,同时口服TJ-19会延迟CBZ的口服吸收,而TJ-19连续1周重复预处理会加速大鼠体内CBZ的代谢,且不影响CBZ的蛋白结合。